Free Trial

UiPath (NYSE:PATH) Stock Price Up 0.6% - Still a Buy?

UiPath logo with Business Services background

UiPath Inc. (NYSE:PATH - Get Free Report)'s stock price rose 0.6% on Wednesday . The stock traded as high as $13.14 and last traded at $13.13. Approximately 2,583,517 shares traded hands during trading, a decline of 73% from the average daily volume of 9,650,370 shares. The stock had previously closed at $13.05.

Wall Street Analyst Weigh In

PATH has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised their price objective on shares of UiPath from $17.00 to $18.00 and gave the company an "overweight" rating in a research note on Friday, December 6th. Bank of America boosted their price objective on shares of UiPath from $16.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Needham & Company LLC reiterated a "hold" rating on shares of UiPath in a report on Thursday, December 19th. DA Davidson lifted their price target on shares of UiPath from $13.00 to $15.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Finally, TD Cowen dropped their price objective on UiPath from $17.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, September 6th. One research analyst has rated the stock with a sell rating, sixteen have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, UiPath presently has an average rating of "Hold" and an average target price of $17.50.

Read Our Latest Report on UiPath

UiPath Stock Up 0.6 %

The firm has a fifty day moving average of $13.44 and a 200-day moving average of $12.65. The firm has a market cap of $7.22 billion, a P/E ratio of -82.06 and a beta of 0.94.

Institutional Investors Weigh In On UiPath

Several large investors have recently made changes to their positions in PATH. Raymond James & Associates raised its position in UiPath by 40.3% during the second quarter. Raymond James & Associates now owns 230,331 shares of the company's stock worth $2,921,000 after acquiring an additional 66,114 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of UiPath by 20.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,552,921 shares of the company's stock valued at $32,371,000 after purchasing an additional 439,344 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in UiPath in the 2nd quarter valued at about $396,000. Nations Financial Group Inc. IA ADV bought a new position in UiPath during the second quarter worth about $310,000. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its stake in UiPath by 5.5% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 41,421 shares of the company's stock valued at $525,000 after buying an additional 2,158 shares during the period. Institutional investors and hedge funds own 62.50% of the company's stock.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Should you invest $1,000 in UiPath right now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Unveils Game-Changing Tech, But Stock Dips
Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines